Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Alzheimer’s diseases

Tag: Alzheimer’s diseases

  • BiotechToday
  • World

Levetiracetam, an anti-seizure drug & its effect on Alzheimer’s

BioTech Today October 18, 2021October 18, 2021 1

Komal Bavaskar, D Y Patil University Alzheimer’s disease affects around 5.8 million Americans aged 65 and over. 80% of those surveyed are 75 or older. In India, more than 4 million people are affected by this disease. Alzheimer’s disease is thought to affect between 60% and 70% of the approximately 50 million individuals globally who […]

Read More
  • BiotechToday
  • World

Alzheimer’s disease and the liver: Are they linked?

BioTech Today October 1, 2021October 1, 2021 1

Sribas Chowdhury, Adamas University, Kolkata Neurodegenerative diseases like Alzheimer’s are some of the most complicated diseases existing amongst modern humankind. These diseases are often complicated to understand. And since their causative agents are unknown in 80% of cases, their treatment is even more challenging. Primarily, the reasons associated with AD were mainly centered around the […]

Read More
  • BiotechToday
  • World

A rare and aggressive form of early onset Alzheimer’s disease

BioTech Today September 7, 2021September 7, 2021 1

Anjali Kumari, IILM College of Engineering and Technology The international team of scientists in Sweden has discovered a new gene mutation that is linked to the early onset of the Alzheimer’s disease. This has been done by tracing the DNA flaw through various members of a single family. What is Alzheimer’s disease? Alzheimer’s also called […]

Read More
  • BiotechToday
  • World

A study of mortality from Alzheimer’s disease & other dementias

bioxone August 6, 2021August 5, 2021 3

Ananya Ghosal, MAKAUT(WB) 40-50 million people are suffering from Alzheimer’s and other dementias worldwide. Due to the tendency of population aging and population growth, the number may rise to 100 million people suffering from the disease by 2050. From the population-based epidemiological study, dementia has been underreported on death certificates, even after including all contributing […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy